Platelet Rich Plasma Market in Europe – Industry Insights

According to FutureWise analysis the europe platelet rich plasma market in 2025 is US$ 156.2 million, and is expected to reach US$ 508.11 million by 2033 at a CAGR of 15.89%. The increasing adoption of regenerative therapies in fields such as orthopedics, aesthetics, and sports medicine is contributing to significant growth in this sector. A growing awareness of the minimally invasive nature of platelet-rich plasma (PRP) therapy, combined with its effectiveness in promoting tissue healing, is driving demand in several key European countries, including Germany, France, and the UK.

Platelet-rich plasma (PRP), also referred to as autologous conditioned plasma, is a specialized concentrate derived from whole blood that is rich in plasma proteins and platelets. This concentrate is obtained through a centrifugation process that effectively separates red blood cells from plasma.

The European platelet-rich plasma market encompasses the evaluation of market size for both PRP systems and PRP kits. This market report includes a detailed analysis of the market value in Europe, categorized by product type, applications, end-users, and individual countries.

Included in the report are various PRP systems, which consist of centrifuge systems specifically designed for the separation of platelet-rich plasma from platelet-poor plasma using autologous blood samples collected in point-of-care facilities. It is important to note that other centrifuge systems intended for different cellular therapies or the preparation of substances derived from bodily fluids are not covered in this report.

Examples of PRP systems featured in the report include the GPS® III Platelet Concentration System from Zimmer Biomet, Arthrex ACP® Double Syringe System, and Arthrex Angel® cPRP Processing System from Arthrex Inc., among others.

The report also highlights PRP kits, which are integral to the preparation of platelet-rich plasma. These kits typically include essential components such as PRP tubes, re-suspension tubes, injectors, needles, and phlebotomy sets, designed for efficient and cost-effective PRP extraction.

PRP kits are distributed to end-users through three major sales channels: direct sales, distributor sales, and other channels, which include group purchasing organizations, wholesalers, and pharmacies.

New PRP Systems and Devices: Arthrex, Inc. launched the ACP Max™ PRP System in April 2025. Its key features include a larger blood draw volume and a double-syringe, double-spin design, enabling higher platelet concentrations and more growth factors per dose.

FutureWise Market Research has published a report that provides an insightful analysis of Europe Platelet Rich Plasma Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=136&type=requestsample

Europe Platelet Rich Plasma Market Segmentation:

By Product Type

• Instruments
• Kits
  • Kit By Type
    • Pure Platelet-Rich Plasma (P-PRP)
    • Leukocyte-Rich Platelet-Rich Plasma (L-PRP)
    • Leukocyte-Platelet-Rich Fibrin (L-PRF)
    • Pure Platelet-Rich Fibrin (P-PRF)
  • Kit By Origin
    • Autologous Platelet-Rich Plasma
    • Homologous Platelet-Rich Plasma
    • Allogeneic Platelet-Rich Plasm

By Application

• Cosmetic/Aesthetic/Hair Fall Treatment
• Orthopedics/Rehabilitation medicine
• Dentistry
• Ophthalmology
• Research and Development
• Veterinary

By End Users

• Physician's office/Private Practice/Veterinary Clinics
• Hospitals
• Orthopedic Clinics
• Cosmetic/dermatology/Trichology Clinics
• Academic and Research Institutes

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Europe Platelet Rich Plasma Market:

• Terumo BCT
• Zimmer Biomet
• NeoGenesis Co. Ltd
• Glofinn oy Overview
• T Biotechnology (T Lab)
• Regen Lab SA, SDD Medical Group Ltd Overview
• IntraVita International Limited Overview
• Exactech Inc.
• Arthrex Inc.
• Biotechnology Institute (bti)

Recent developments by key players in Europe Platelet Rich Plasma Market:

Arthrex Inc.

• In April 2025, the ACP Max™ PRP System was introduced, featuring a larger blood draw and an innovative double-spin, double-syringe design that provides elevated platelet concentrations and an increased amount of growth factors per dose, establishing it as a next-generation PRP device in the fields of orthopedics and regenerative medicine.
• January 2024: Showcased the practical application of ACP Max utilizing PRP with low neutrophil content, emphasizing its commitment to precision and enhanced patient results.

T Biotechnology (T Lab)

By early 2025, the T-Lab was acknowledged as the top PRP system at the IMCAS World Congress, following an impartial assessment of seven worldwide systems. T-Lab distinguished itself with an outstanding platelet count of 4.6 billion platelets and a recovery rate of 90.1%—providing substantial confirmation of its effectiveness in Europe.

Terumo BCT

In October 2024, initiated a decade-long partnership with the Sanquin Blood Supply Foundation in the Netherlands to implement the automated Reveos™ Blood Processing System. This initiative seeks to enhance the efficiency of plasma and platelet processing, ultimately reinforcing the PRP production framework across Europe.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=136&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Europe Platelet Rich Plasma Market By Product Type, By Application, By End Users and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com

Article source: https://article-realm.com/article/Health-Fitness/77775-Platelet-Rich-Plasma-Market-in-Europe-Industry-Insights.html